The present study aims at preparing an Emulgel formulation of Meloxicam using emulsifiers and various gelling agents along with the use of. PDF | Emulgel is one of the recent technologies in NDDS used for dual control release of emulsion and gel for topical use. The stability of. PDF | Topical therapies in cream, ointment, gel and lotion formulation, are an important component of dermatological therapeutic.

Author: Dailabar Kajiran
Country: Germany
Language: English (Spanish)
Genre: Health and Food
Published (Last): 4 February 2009
Pages: 125
PDF File Size: 18.47 Mb
ePub File Size: 6.94 Mb
ISBN: 358-5-36102-485-4
Downloads: 37535
Price: Free* [*Free Regsitration Required]
Uploader: Fekazahn

They also exhibited higher drug release and antifungal activity than the CHL powder. Rheological studies revealed that the CHL emulgels exhibited a shear-thinning behavior with thixotropy. Medical Applications of Controlled Release.

Marcel Dekker Inc; The Complete Drug Reference. Bioavailability of salbutamol sulphate from different suppository formulations. The drug release from all the emulgels was found to follow diffusion-controlled mechanism.

There was a problem providing the content you requested

Author fornulation Article notes Copyright and License information Disclaimer. Lea and Febiger; Preparation of an emulgel for treatment of aphthous ulcer on the basis of carbomers.


Please review our privacy policy. This article has been cited by other articles in PMC. The prepared emulgels were evaluated for their physical appearance, rheological behavior, drug release, antifungal activity, and stability.

Formulation and stability of chloramphenicol gel and emulgel.

The influence of the type of the gelling agent and the concentration of both the oil phase and emulsifying agent on the drug release from the prepared emulgels was investigated using a 2 3 factorial design. Stability studies showed that the physical appearance, rheological properties, ejulgel release, and antifungal activity in all the prepared emulgels remained unchanged upon storage for 3 months.

Optimization of chlorphenesin emulgel formulation

Received Dec 31; Accepted May Analysis of data on the medicament release from ointments. Formulation and evaluation of topical preparations containing phenol and local vesicants. As a general conclusion, it was suggested that the CHL emulgel formulation prepared with HPMC with the oil phase concentration in its low level and emulsifying agent concentration in its high level was the formula of choice since it showed the highest drug release and antifungal activity.

Az J Pharm Sci. Transdermal controlled release systems. Commercially available CHL topical powder was used for comparison.

Support Center Support Center. The Pharmaceutical Press; Encyclopedia of Pharmaceutical Technology. Published online Sep 1.


Egypt J Pharm Sci. The Theory and Practice of Industrial Pharmacy.

Development of a thermoreversible gel for controlled-release ocular delivery of diclofenac sodium. All the prepared emulgels showed acceptable physical properties concerning color, homogeneity, consistency, spreadability, and pH value.

Optimization of chlorphenesin emulgel formulation

National Center for Biotechnology InformationU. It was found that the emulsifying agent concentration had the most pronounced effect on the drug release from the emulgels followed by the oil phase concentration and finally the type of the gelling agent.

A study of shear and compression deformations on hydrophilic gels of tretinoin. Blackwell Scientific Publications; Abstract This study was conducted to develop an emulgel formulation of chlorphenesin CHL using 2 types of gelling agents: Swarbrick J, Boylan JC, editors. This study was conducted to develop an emulgel formulation of chlorphenesin CHL using 2 types of gelling agents: